Philip Morris International’s Latest Scientific Update Examines How Cutting-Edge Research Is Opening New Areas of Business
Philip Morris International Inc. (PMI) (NYSE: PM) today releases the latest issue of its Scientific Update, a publication devoted to research efforts to develop and assess a range of smoke-free alternatives to cigarettes, as well as products beyond nicotine.
In this issue, PMI reviews milestones from 2020, examines advances in multiple fields of research arising from its smoke-free product assessments, and discusses the company’s new research initiatives. Announced in February of this year, these initiatives focus on products that contain neither tobacco nor nicotine, with initial areas of exploration including respiratory drug delivery and botanicals. These efforts run in parallel to PMI’s ongoing work to phase out cigarettes by encouraging those adults who would otherwise continue to smoke to switch to less harmful, smoke-free products.
“With our work in these new areas, we are looking to contribute to a better future. We have a lot to offer the world, and it would be inconsistent with our scientific mission not to use our knowledge to expand into new solutions-based areas such as respiratory drug delivery and botanical products,” said Dr. Jorge Insuasty, Chief Life Sciences Officer. “We are leveraging those areas in which we have strong research and technology expertise to strengthen our business while making a difference for society.”
The May 2021 issue of the Scientific Update also details some of the ways in which PMI’s ongoing research is impacting various fields of science. These include developing a better understanding of the human airway, research and development on aerosols for inhalation, advancing methods in toxicology, and working to minimize animal studies in scientific research, among other examples.
Several science-related milestones from 2020 are also reviewed, including the decision by the U.S. Food and Drug Administration to authorize the marketing of the IQOS tobacco heating system as a modified risk tobacco product (MRTP), with reduced exposure information. Another milestone is the creation of PMI’s Open Science online conference series, an ongoing program in which PMI scientists present their research and answer audience questions live. The next event—“The Challenge of Measuring the Use of Nicotine-Containing Products”—will take place on June 10. Register here.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the U.S., where these products have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a modified risk tobacco product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI’s smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of March 31, 2021, PMI’s smoke-free products are available for sale in 66 markets in key cities or nationwide, and PMI estimates that approximately 14 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Philip Morris International
T. +41 (0)79 843 8603
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Climate Pledge Announces 86 New Signatories, Including Procter & Gamble, HP, and Salesforce, Signaling Their Commitment to Achieving Net-Zero Carbon by 2040 or Sooner20.9.2021 12:00:00 CEST | Press release
Today, Amazon and Global Optimism announced that more than 200 companieshave now signed The Climate Pledge. The 86 new signatories joining The Climate Pledge include Procter & Gamble, HP, Salesforce, ASOS, and Nespresso. Pledge signatories in total generate over $1.8 trillion in global annual revenues and have more than 7 million employees across 26 industries in 21 countries. By achieving net-zero carbon by 2040, 10 years ahead of the Paris Agreement, current Climate Pledge signatories are expected to collectively mitigate 1.98 billion metric tons (BMT) of carbon emissions from a 2020 baseline. This is equivalent to 5.4% of current global annual emissions—demonstrating the collective impact The Climate Pledge is expected to have in addressing climate change and prompting more action to tackle the climate crisis. Signatories to The Climate Pledge agree to: Measure and report greenhouse gas emissions on a regular basis. Implement decarbonization strategies in line with the Paris Agreeme
AlbaCore Capital Group Continues to Expand with Three Senior Hires20.9.2021 11:20:00 CEST | Press release
European credit specialist AlbaCore Capital Group (“AlbaCore”), today announces three senior hires to reinforce its Operations, Business Development and Investor Relations teams. As part of the growth of the AlbaCore platform, investing across the European credit spectrum with $8.5bn1 AUM, AlbaCore has bolstered its senior executive group. Jenny Fung is appointed as Managing Director of Investor Relations in New York to further expand global investor relationships and our commitment to the region. Tara Mulholland joins as Head of Business Transformation and Micaela Kelley as Deputy Chief Operating Officer to support Matthew Courey, Chief Operating Officer and Founding Partner. Jenny brings a wealth of financial services experience with 25 years in the industry. She joins from Taconic Capital, a global investment firm, where she was Director of Marketing and Investor Relations for 13 years, and prior to that at Bank of America, AIG and CSFB. Tara will oversee an operational change progr
Cedo Reveals Roadmap for Sustainable Business Growth20.9.2021 09:00:00 CEST | Press release
Cedo, one of Europe’s largest manufacturers of recycled plastic waste bags has today revealed its Roadmap for Sustainable Business Growth. The plan is built on three pillars: People, Planet and Products and comes with targets designed to protect the earth’s resources while attracting and nurturing talent within the business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210920005048/en/ Cedo CEO, Rik De Vos, says “Cedo is proud of our contribution to achieving the goals of sustainable business development outlined by the UN” (Photo: Business Wire) “Our plan has been built with deep engagement from all the employees within our company,” says Rik De Vos, CEO of Cedo. “The journey to circularity will not be easy, but I have seen an immediate shift in decision making, and prioritisation of actions now that we are a purpose-led business. We are actively contributing to European and UK legislative debate to accelerate this transf
Coffee Pod Convenience Without the Landfill Guilt: Introducing the Home-Compostable Coffee Capsule, Co-Developed by Jabil and Prosol20.9.2021 08:00:00 CEST | Press release
Jabil Packaging Solutions (JPS), a division of manufacturing solutions provider Jabil Inc. (NYSE: JBL), today announced a significant advancement in coffee pod sustainability with the launch of their home-compostable coffee capsule for single serve espresso brewers. This high-barrier coffee capsule improves on existing solutions by eliminating the need for a plastic or foil pouch that is sometimes required to preserve freshness in compostable coffee capsules. JPS co-developed the compostable coffee capsule with Productos Solubles S.A. (Prosol), a leading European coffee roaster, based in Palencia, Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210919005012/en/ Co-developed by Jabil Packaging Solutions and Productos Solubles S.A. (Prosol), the home-compostable coffee capsule improves on existing solutions and is a significant advancement in coffee pod sustainability. (Photo: Business Wire) The technically complex coffe
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)18.9.2021 15:34:00 CEST | Press release
Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one underlying medical condition (the obese, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents) with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. This marks the first time a monoclonal antibody treatment for COVID-19 has received a full approval to treat patients with COVID-19 from the Korean MFDS. In February, the Korean MFDS granted a Conditional Marketing Authorisation (CMA) for the emergency use of regdanvimab (CT-P59) and allowed the use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, high blood pressure) w
Ipsen: ESMO 2021: Cabometyx ® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 06:30:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021
Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 20:46:00 CEST | Press release
Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005495/en/ Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom